Cargando…
Innovative therapeutic targets in chronic sinusitis with nasal polyps()
Autor principal: | Bachert, Claus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444638/ https://www.ncbi.nlm.nih.gov/pubmed/27083137 http://dx.doi.org/10.1016/j.bjorl.2016.03.001 |
Ejemplares similares
-
Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps
por: Bachert, Claus, et al.
Publicado: (2021) -
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
por: Bachert, Claus, et al.
Publicado: (2022) -
Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art
por: Ren, Lei, et al.
Publicado: (2019) -
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status
por: Fujieda, Shigeharu, et al.
Publicado: (2021) -
Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement
por: Lou, Hongfei, et al.
Publicado: (2018)